{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:25:12Z","timestamp":1786998312161,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62071099"],"award-info":[{"award-number":["62071099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62371112"],"award-info":[{"award-number":["62371112"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Methods"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ymeth.2024.11.005","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T11:55:21Z","timestamp":1731671721000},"page":"11-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Ab-Amy 2.0: Predicting light chain amyloidogenic risk of therapeutic antibodies based on antibody language model"],"prefix":"10.1016","volume":"233","author":[{"given":"Yuwei","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziru","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunarathne","family":"Samarappuli Mudiyanselage Savini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lening","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ymeth.2024.11.005_b0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s43556-022-00100-4","article-title":"Development of therapeutic antibodies for the treatment of diseases","volume":"3","author":"Wang","year":"2022","journal-title":"Mol Biomed"},{"issue":"2","key":"10.1016\/j.ymeth.2024.11.005_b0010","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s43018-023-00516-z","article-title":"Advances in antibody-based therapy in oncology","volume":"4","author":"Zinn","year":"2023","journal-title":"Nat Cancer"},{"issue":"8","key":"10.1016\/j.ymeth.2024.11.005_b0015","doi-asserted-by":"crossref","first-page":"674","DOI":"10.2174\/1574893617666220408085405","article-title":"Genetic Variants of HLA-DRB1 Alleles and the Chance of Developing Rheumatoid Arthritis: Systematic Review and Meta-Analysis","volume":"17","author":"Mengesha","year":"2022","journal-title":"Current Bioinformatics"},{"issue":"6","key":"10.1016\/j.ymeth.2024.11.005_b0020","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.7150\/ijbs.59149","article-title":"Development and application of therapeutic antibodies against COVID-19","volume":"17","author":"Ning","year":"2021","journal-title":"Int J Biol Sci"},{"issue":"1","key":"10.1016\/j.ymeth.2024.11.005_b0025","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2022.2153410","article-title":"Antibodies to watch in 2023","volume":"15","author":"Kaplon","year":"2023","journal-title":"Mabs"},{"issue":"1","key":"10.1016\/j.ymeth.2024.11.005_b0030","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2297450","article-title":"Antibodies to watch in 2024","volume":"16","author":"Crescioli","year":"2024","journal-title":"Mabs"},{"issue":"5","key":"10.1016\/j.ymeth.2024.11.005_b0035","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1073\/pnas.1616408114","article-title":"Biophysical properties of the clinical-stage antibody landscape","volume":"114","author":"Jain","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.ymeth.2024.11.005_b0040","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2171248","article-title":"Assessing developability early in the discovery process for novel biologics","volume":"15","author":"Fern\u00e1ndez-Quintero","year":"2023","journal-title":"Mabs"},{"key":"10.1016\/j.ymeth.2024.11.005_b0045","doi-asserted-by":"crossref","DOI":"10.1007\/s12539-024-00613-2","article-title":"DOTAD: A Database of Therapeutic Antibody Developability","author":"Li","year":"2024","journal-title":"Interdiscip Sci"},{"issue":"26","key":"10.1016\/j.ymeth.2024.11.005_b0050","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.2174\/0109298673264899231206093930","article-title":"In Silico Immunogenicity Assessment of Therapeutic Peptides","volume":"31","author":"Li","year":"2024","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ymeth.2024.11.005_b0055","doi-asserted-by":"crossref","first-page":"842127","DOI":"10.3389\/fgene.2022.842127","article-title":"SSH2.0: A Better Tool for Predicting the Hydrophobic Interaction Risk of Monoclonal Antibody","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Genet"},{"issue":"3","key":"10.1016\/j.ymeth.2024.11.005_b0060","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.cjca.2019.12.033","article-title":"Amyloidosis as a Systemic Disease in Context","volume":"36","author":"Cuddy","year":"2020","journal-title":"Can J Cardiol"},{"issue":"3","key":"10.1016\/j.ymeth.2024.11.005_b0065","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ki.2012.433","article-title":"Non-light-chain immunoglobulin amyloidosis: time to expand or refine the spectrum to include light+heavy chain amyloidosis?","volume":"83","author":"Picken","year":"2013","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.ymeth.2024.11.005_b0070","first-page":"770","article-title":"Systemic amyloidosis: novel therapies and role of biomarkers","volume":"32","author":"Nuvolone","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.ymeth.2024.11.005_b0075","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/bjh.16436","article-title":"Monoclonal antibodies in the treatment of AL amyloidosis: co-targetting the plasma cell clone and amyloid deposits","volume":"189","author":"Popkova","year":"2020","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.ymeth.2024.11.005_b0080","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25051195","article-title":"Structure and aggregation mechanisms in amyloids","volume":"25","author":"Almeida","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ymeth.2024.11.005_b0085","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1471-2105-8-65","article-title":"AGGRESCAN: a server for the prediction and evaluation of \u201chot spots\u201d of aggregation in polypeptides","volume":"8","author":"Conchillo-Sol\u00e9","year":"2007","journal-title":"BMC Bioinformatics"},{"issue":"3","key":"10.1016\/j.ymeth.2024.11.005_b0090","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nmeth.1432","article-title":"Exploring the sequence determinants of amyloid structure using position-specific scoring matrices","volume":"7","author":"Maurer-Stroh","year":"2010","journal-title":"Nat Methods"},{"key":"10.1016\/j.ymeth.2024.11.005_b0095","doi-asserted-by":"crossref","unstructured":"I. Walsh, F. Seno, S.C. Tosatto, A. Trovato, PASTA 2.0: an improved server for protein aggregation prediction, Nucleic Acids Res, 42(Web Server issue) (2014) W301-7. https:\/\/doi.org\/10.1093\/nar\/gku399.","DOI":"10.1093\/nar\/gku399"},{"issue":"6","key":"10.1016\/j.ymeth.2024.11.005_b0100","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jalz.2014.06.007","article-title":"A structure-based approach to predict predisposition to amyloidosis","volume":"11","author":"Ahmed","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"5","key":"10.1016\/j.ymeth.2024.11.005_b0105","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1096\/fj.09-145979","article-title":"Beta arcades: recurring motifs in naturally occurring and disease-related amyloid fibrils","volume":"24","author":"Kajava","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.ymeth.2024.11.005_b0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2105-11-79","article-title":"Using simple artificial intelligence methods for predicting amyloidogenesis in antibodies","volume":"11","author":"David","year":"2010","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"10.1016\/j.ymeth.2024.11.005_b0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053235","article-title":"Prediction and analysis of antibody amyloidogenesis from sequences","volume":"8","author":"Liaw","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ymeth.2024.11.005_b0120","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1038\/s41467-021-23880-9","article-title":"Machine learning analyses of antibody somatic mutations predict immunoglobulin light chain toxicity","volume":"12","author":"Garofalo","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ymeth.2024.11.005_b0125","doi-asserted-by":"crossref","first-page":"13785","DOI":"10.1038\/s41598-021-93019-9","article-title":"Exploring the sequence features determining amyloidosis in human antibody light chains","volume":"11","author":"Rawat","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.ymeth.2024.11.005_b0130","first-page":"147","article-title":"AB-Amy: machine learning aided amyloidogenic risk prediction of therapeutic antibody light chains","volume":"6","author":"Zhou","year":"2023","journal-title":"Antib Ther"},{"issue":"1","key":"10.1016\/j.ymeth.2024.11.005_b0135","doi-asserted-by":"crossref","first-page":"12961","DOI":"10.1038\/s41598-017-13210-9","article-title":"Amyloidogenic motifs revealed by n-gram analysis","volume":"7","author":"Burdukiewicz","year":"2017","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.ymeth.2024.11.005_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134679","article-title":"Prediction of peptide and protein propensity for amyloid formation","volume":"10","author":"Fam\u00edlia","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ymeth.2024.11.005_b0145","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ymeth.2023.07.003","article-title":"Deep learning in preclinical antibody drug discovery and development","volume":"218","author":"Zhou","year":"2023","journal-title":"Methods"},{"issue":"2","key":"10.1016\/j.ymeth.2024.11.005_b0150","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/nar\/gkad1128","article-title":"Language model-based B cell receptor sequence embeddings can effectively encode receptor specificity","volume":"52","author":"Wang","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.ymeth.2024.11.005_b0155","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1186\/s12859-022-05010-4","article-title":"Prediction of polyreactive and nonspecific single-chain fragment variables through structural biochemical features and protein language-based descriptors","volume":"23","author":"Lim","year":"2022","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ymeth.2024.11.005_b0160","doi-asserted-by":"crossref","unstructured":"S. Wang., B. Ma., Deep learning boosted amyloidosis diagnosis, 2023 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), (2023) pp.57-62. https:\/\/doi.org\/10.1109\/BIBM58861.2023.10385917.","DOI":"10.1109\/BIBM58861.2023.10385917"},{"issue":"1","key":"10.1016\/j.ymeth.2024.11.005_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13506120802676781","article-title":"AL-Base: a visual platform analysis tool for the study of amyloidogenic immunoglobulin light chain sequences","volume":"16","author":"Bodi","year":"2009","journal-title":"Amyloid"},{"issue":"D1","key":"10.1016\/j.ymeth.2024.11.005_b0170","doi-asserted-by":"crossref","first-page":"D383","DOI":"10.1093\/nar\/gkz827","article-title":"Thera-SAbDab: the Therapeutic Structural Antibody Database","volume":"48","author":"Raybould","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"6637","key":"10.1016\/j.ymeth.2024.11.005_b0175","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1126\/science.ade2574","article-title":"Evolutionary-scale prediction of atomic-level protein structure with a language model","volume":"379","author":"Lin","year":"2023","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.ymeth.2024.11.005_b0180","doi-asserted-by":"crossref","first-page":"7112","DOI":"10.1109\/TPAMI.2021.3095381","article-title":"ProtTrans: Toward Understanding the Language of Life Through Self-Supervised Learning","volume":"44","author":"Elnaggar","year":"2022","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"issue":"1","key":"10.1016\/j.ymeth.2024.11.005_b0185","article-title":"AbLang: an antibody language model for completing antibody sequences","volume":"2","author":"Olsen","year":"2022","journal-title":"Bioinform Adv"},{"key":"10.1016\/j.ymeth.2024.11.005_b0190","unstructured":"J.A. Ruffolo, J.J. Gray, J. Sulam, Deciphering antibody affinity maturation with language models and weakly supervised learning, arXiv preprint, (2021). https:\/\/doi.org\/10.48550\/arXiv.2112.07782."},{"issue":"1","key":"10.1016\/j.ymeth.2024.11.005_b0195","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12882-023-03207-0","article-title":"Light and heavy chain deposition disease with focal amyloid deposition diagnosed with mass spectrometry: a case report","volume":"24","author":"Shimamoto","year":"2023","journal-title":"BMC Nephrol"}],"container-title":["Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104620232400241X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104620232400241X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T03:15:11Z","timestamp":1733714111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104620232400241X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":39,"alternative-id":["S104620232400241X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymeth.2024.11.005","relation":{},"ISSN":["1046-2023"],"issn-type":[{"value":"1046-2023","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ab-Amy 2.0: Predicting light chain amyloidogenic risk of therapeutic antibodies based on antibody language model","name":"articletitle","label":"Article Title"},{"value":"Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymeth.2024.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}